This inventor holds 2 USPTO granted patents. Top assignee: Mcneil-Ppc, Inc.. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: Dinesh Patel: Innovator in Pharmaceutical Formulations
Introduction
Dinesh Patel is a notable inventor based in Kendall Park, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. With a total of 2 patents, Patel's work focuses on creating effective and sustained-release medications.
Latest Patents
Patel's latest patents include a tablet containing cetirizine, pseudoephedrine, and naproxen with a barrier layer. This invention features a unique design that includes a first drug layer with naproxen, a second sustained-release drug layer with pseudoephedrine, and a barrier layer that separates the first and third drug layers. The third drug layer contains cetirizine, ensuring that the active ingredients are delivered effectively over an extended period. Another significant patent is a three-layer tablet that also includes cetirizine, pseudoephedrine, and naproxen. This design ensures that the first drug layer is in contact with the second, while the third drug layer is only in contact with the second, optimizing the therapeutic effects of the medication.
Career Highlights
Dinesh Patel is currently associated with McNeil-PPC, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that enhance patient care and medication efficacy.
Collaborations
Patel has collaborated with notable colleagues, including Indukumar G Shah and Michael Nichols, contributing to a dynamic team focused on pharmaceutical advancements.
Conclusion
Dinesh Patel's contributions to pharmaceutical innovations highlight his commitment to improving drug delivery systems. His patents reflect a deep understanding of medication formulation, which benefits both healthcare providers and patients alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile